Donald Thomas
Thoracic Surgery (Cardiothoracic Vascular Surgery) · Oxnard, CANPI 1609961671
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (57.4%), travel and lodging and education — rather than concentrated in one kind of arrangement. 23 manufacturers reported payments, led by Atricure, Inc. at 34.0% of the total. Reporting peaked in 2021 at $2,489 and has fallen 98.9% since, to $28 in 2025. That places this record below the midpoint for thoracic surgery (cardiothoracic vascular surgery) clinicians in CA, where the typical reported total is $4,430.
Across 73 payments — averaging $74.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Atricure, Inc.$2K
- Abbott$2K
- Abiomed$390
- Medtronic$240
- Edwards Lifesciences$211
- Novartis$190
- plus $749 from 17 others
Across 3 payments — averaging $434.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Atricure, Inc.$1K
What the payments were for
- Travel & lodging$2,33243%
- Food & beverage$3,14157%
- Education$10%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Atricure, Inc. | 9 | $1,862 |
| Abbott | 16 | $1,832 |
| Abiomed | 4 | $390 |
| Medtronic(2 entities) | 5 | $240 |
| Edwards Lifesciences | 3 | $211 |
| Novartis | 9 | $190 |
| AstraZeneca | 4 | $170 |
| Zimmer Biomet | 1 | $143 |
| La Jolla Pharmaceutical Company | 3 | $63 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $47 |
| Alnylam Pharmaceuticals Inc. | 2 | $44 |
| Amgen | 2 | $37 |
| Merck | 2 | $30 |
| Kls-martin L.p. | 1 | $29 |
| Endotronix, Inc. | 1 | $28 |
| Bolton Medical Inc | 2 | $24 |
| Esperion Therapeutics, Inc. | 1 | $24 |
| Terumo Cardiovascular Systems Corporation | 1 | $21 |
| Amarin Pharma, Inc. | 1 | $20 |
| Cook Medical LLC | 1 | $19 |
| Biom'up France SAS | 1 | $19 |
| LSI Solutions Inc | 1 | $18 |
| Getinge USA Sales, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,474 in reported general payments places this provider in the 50th percentile of 546 thoracic surgery (cardiothoracic vascular surgery) providers in California.
See all thoracic surgery (cardiothoracic vascular surgery) providers in California →
Other thoracic surgery (cardiothoracic vascular surgery) in Oxnard
- Thomas FogartyPortola Valley$3.7M
- Steven GundryPalm Springs$1.6M
- Armin KiankhooySaint Helena$941K
- Ara KlijianMurrieta$916K
- Gregory FontanaThousand Oaks$875K
- Gansevoort DunningtonSaint Helena$764K
- Wilson TsaiWalnut Creek$680K
- Fernando FleischmanLos Angeles$608K
- Harmik SoukiasianLos Angeles$577K
- Ali KhoynezhadLong Beach$476K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.